Related Experiment Video
Updated: Dec 30, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Sharing lessons learnt across European cardiovascular research consortia
Lisette de Jong1, Ivana Bobeldijk-Pastorova2, Jeanette Erdmann3
1Freelance Science Journalist, Soest, Netherlands.
European research consortia can enhance their impact by collaborating. Sharing knowledge and resources between independent cardiovascular disease drug target projects, funded by the same EU Horizon2020 call, improved outcomes and efficiency.
Area of Science:
- Biomedical Research
- Drug Discovery
- Cardiovascular Diseases
Background:
- European research consortia frequently experience competition for resources and recognition.
- Independent consortia, funded by the EU Horizon2020 call, focused on novel cardiovascular disease drug targets.
- Each consortium pursued distinct research strategies.
Purpose of the Study:
- To explore the benefits of inter-consortia collaboration for enhancing scientific impact and efficiency.
- To share lessons learned from a collaborative approach between independent research projects.
- To encourage future consortia to adopt knowledge-sharing strategies.
Main Methods:
- Consortia coordinators initiated knowledge sharing at an agreed project stage.
- Information exchange focused on research strategies, visions, and ideas.
- The approach aimed to leverage shared insights for mutual benefit.
Main Results:
- Intensified interaction was envisioned to increase impact, outcomes, and efficiency.
- The paper documents the learning experiences from this collaborative initiative.
- The study highlights the potential advantages of cross-consortia cooperation.
Conclusions:
- Collaboration between independent research consortia can yield significant benefits.
- Sharing knowledge and resources can overcome competitive challenges.
- This approach offers a model for future research endeavors to maximize scientific impact.
More Related Videos
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
05:30Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Coronary Artery Disease I: Introduction